Biopol Chemicals
BIOPOL NSE
Biopol Chemicals
ChemicalsNSE: BIOPOL Specialty Chemicals
Key Fundamentals
SMESpecialty ChemicalsChemicalsMarket Cap
₹49.27 Cr
Volatility
Low Risk
P/E Ratio
0
EBITDA
₹13.70 Cr
Return on Equity
17.98%
Debt to Equity
0.57
Book Value
₹46.2
52W High
₹133.75
52W Low
₹39.5
Tapetide Score
Data-driven rating, 0–100. How it works →
Growth Rate
Revenue Growth
65.45% higher than
3Y
Net Income Growth
109% lower than
3Y
Cash Flow Change
-430% lower than
3Y
ROE
-43.33% lower than
3Y
ROCE
-45.02% higher than
3Y
EBITDA Margin (Avg.)
27.74% higher than
3Y
Quarterly Results
| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 33 | 42 | 30 | 53 | 73 | 60 | 51 | 86 | 47 |
| Expenses | 33 | 38 | 28 | 46 | 68 | 51 | 45 | 77 | 41 |
| Operating Profit | 1 | 5 | 1 | 7 | 5 | 9 | 6 | 9 | 6 |
| OPM % | 2% | 11% | 4% | 13% | 7% | 14% | 12% | 10% | 13% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| PBT | 0 | 4 | 0 | 5 | 3 | 5 | 3 | 6 | 3 |
| Tax % | 58% | 4% | 46% | 6% | 6% | 0% | 8% | 3% | 8% |
| Net Profit | 0 | 4 | 0 | 5 | 3 | 5 | 3 | 6 | 3 |
| EPS in Rs | 0.14 | 5.22 | 0.14 | 4.57 | 2.65 | 4.89 | 2.56 | 5.85 | 2.51 |
Profit & Loss
| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Sales | 25.42 | 49.13 |
| Expenses | 20.99 | 42.59 |
| Operating Profit | 4.43 | 6.54 |
| OPM % | 17.43% | 13.31% |
| Other Income | 0 | 0.02 |
| Interest | 0.39 | 0.68 |
| Depreciation | 0.08 | 0.07 |
| PBT | 3.96 | 5.81 |
| Tax % | 25.25% | 25.13% |
| Net Profit | 2.96 | 4.34 |
| EPS in Rs | 3.74 | 5.49 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Equity Capital | 7.91 | 7.91 |
| Reserves | 1.29 | 5.63 |
| Borrowings | 3.58 | 7.68 |
| Other Liabilities | 4.77 | 10.26 |
| Total Liabilities | 17.55 | 31.48 |
| Fixed Assets | 0.21 | 0.23 |
| CWIP | 0.06 | 0 |
| Investments | 0 | 0 |
| Other Assets | 17.28 | 31.25 |
| Total Assets | 17.55 | 31.48 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Operating | -6.44 | -2.34 |
| Investing | -0.64 | -0.02 |
| Financing | 7.14 | 3.43 |
| Net Cash Flow | 0.06 | 1.07 |
Ratios
| Particulars | Mar 2024 | Mar 2025 |
|---|---|---|
| Debtor Days | 145 | 124 |
| Inventory Days | 121 | 107 |
| Days Payable | 77.9 | 77.77 |
| Cash Conversion Cycle | 189 | 153 |
| Working Capital Days | 127 | 95.17 |
| ROCE % | — | 38.18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Biopol Chemicals insights
28 extracted metrics + investor summaries across FY24–FY25.
Documents
1
Certificate under SEBI (Depositories and Participants) Regulations, 2018
14 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026. 14 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.
2
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
13 July 2026 - Biopol Chemicals says Corporate Governance Report not applicable for quarter ended June 30, 2026; RPT rules now apply. 13 July 2026 - Biopol Chemicals says Corporate Governance Report not applicable for quarter ended June 30, 2026; RPT rules now apply.
3
Disclosure under SEBI Takeover Regulations
12 June 2026 - Promoter group filed Regulation 31(1) declaration to NSE on 16 April 2026. 12 June 2026 - Promoter group filed Regulation 31(1) declaration to NSE on 16 April 2026.
4
Outcome of Board Meeting
11 June 2026 - Board appointed Vandan Vij Sarkar and Sukhomoy Das as directors on June 11, 2026; committees reconstituted. 11 June 2026 - Board appointed Vandan Vij Sarkar and Sukhomoy Das as directors on June 11, 2026; committees reconstituted.
5
Appointment
11 June 2026 - Board approved appointments of Vandan Vij Sarkar and Sukhomoy Das on June 11, 2026; committees reconstituted. 11 June 2026 - Board approved appointments of Vandan Vij Sarkar and Sukhomoy Das on June 11, 2026; committees reconstituted.
Frequently Asked Questions about Biopol Chemicals
Where is Biopol Chemicals (760945) listed?
Biopol Chemicals trades as BIOPOL on the NSE.
Which sector does Biopol Chemicals belong to?
Biopol Chemicals is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Biopol Chemicals?
Biopol Chemicals has a market capitalisation of ₹49.27 Cr, which places it in the Small Cap band.
What is the PE ratio of Biopol Chemicals?
Biopol Chemicals trades at a PE ratio of 0.00, against a book value of ₹46.2 per share.
What is the 52-week high and low of Biopol Chemicals?
Over the last 52 weeks Biopol Chemicals has traded between ₹39.5 and ₹133.75.
What is the Return on Equity (ROE) of Biopol Chemicals?
Biopol Chemicals reported a return on equity of 17.98%. Its debt-to-equity ratio is 0.57.
Company Information
Listed 2026-02-13
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/760945.md for Biopol Chemicals: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.